Neuralink is preparing to begin its first human clinical trials of the Blindsight implant in 2026, which aims to restore vision for people with complete blindness.Neuralink Founder Elon Musk ...

The placebo-controlled, double-blind, randomised Phase I trial involved 100 healthy participants.

Add Yahoo as a preferred source to see more of our stories on Google. Alzheimer's disease, the most common form of dementia, is responsible for tens of millions of cases around the world. Jens Kalaene ...

Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced the first patient was dosed in its first-in-human ...

University of New Mexico Health Sciences researchers hope to launch human clinical trials in their quest for a vaccine to prevent the buildup of pathological tau—a protein in the brain associated with ...

A new drug developed by Australian researchers has shown promising results in reducing sepsis in a Phase II clinical trial involving 180 patients. The carbohydrate-based treatment works by calming a ...

Memorial Sloan Kettering Cancer Center's mission is to end cancer. To get there, the famed organization must keep improving clinical care and research, including clinical trials. It has as many as ...

The first healthy volunteers have been dosed in an early clinical trial testing NRG5051, a disease-modifying therapy for ALS and Parkinson's.

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

On January 9th, GENEIII reaffirmed its global leadership in ergothioneine production and scientific validation at the ...